Healthcare Startups funded by Y Combinator (YC) 2024

Ginkgo Bioworks is the organism company. We design custom organisms for customers across multiple markets. We build our foundries to scale the process of organism engineering using software and hardware automation. Organism engineers at Ginkgo learn from nature to develop new organisms that replace technology with biology.

Notable Labs is building a personalized drug discovery platform to identify treatment options for relapsed and refractory cancer patients — starting with blood cancer — to address the long tail of cancer treatment. We look at a person’s actual cancer cells, test combinations of FDA approved drugs, and see which combinations kill the cancer cells and leave the healthy cells alive. We focus on combinations because cancer is often difficult to target with just one drug and starting with a single drug can lead to resistant clones or relapse. We're building a highly automated lab in Foster City running on our custom software and are currently testing relapsed/refractory cancer patients as well as samples from a variety of pharma/biotech partnerships. https://www.notablelabs.com/careers

We make oral drugs to treat and prevent viral infections - like COVID-19.

Diassess Inc. is revolutionizing the way infectious diseases are prevented, diagnosed, and monitored by developing the tools necessary to empower people to become knowledgeable about their health. We produce inexpensive, disposable health diagnostic hardware that transforms any smartphone into a portable, real-time health-monitoring device for rapid, accessible, multiplexed analysis of bodily fluids anywhere in the world.

Clipboard Health exists to lift as many people up the socioeconomic ladder as possible. We dramatically improve lives by letting healthcare professionals turn extra time and ambition into career growth and financial opportunity. We achieve this with our app-based marketplace that connects healthcare facilities and healthcare professionals, allowing healthcare professionals to book on-demand shifts and healthcare facilities to access on-demand talent. Our mission is to enable healthcare professionals to work when and where they want and to enable healthcare facilities to meet their talent needs. Clipboard Health is a fast-growing Series C startup with classic two-sided network effects. We have product-market fit, generate substantial revenue, and we are helping nurses fix healthcare one shift at a time. Clipboard Health is a diverse and inclusive company with a global, remote-first team of hundreds of people. We’ve been featured on YC’s Top Companies and grown our revenue 25x in the last 18 months. We need your help to keep growing so we can serve more healthcare professionals, healthcare facilities, and patients.

Nurx is a telemedicine startup focused on increasing access to healthcare, starting with birth control and PrEP services.

We're a women’s health company making personalized reproductive health information more accessible, earlier in life. We make the same laboratory tests that were previously confined to fertility clinics more accessible for women at home. By arming women with powerful information about their reproductive health, Modern Fertility is closing the fertility information gap and enabling women to own the decisions impacting their bodies and futures. We've raised $22 million from Forerunner Ventures, Maveron, Union Square Ventures, First Round Capital, #Angels and Y Combinator.

DrChrono develops the essential platform and services for modern medical practices to make care more informed, more interactive, and more personalized. The open platform powers telehealth, electronic health record (EHR), practice management, medical billing, and revenue cycle solutions for physicians and patients, and is fully extensible via a robust API and marketplace of applications and services. The platform is used by thousands of physicians and millions of patients, and is facilitating millions of patient appointments and is processing billions of dollars in medical billing. For more information about DrChrono, visit www.drchrono.com

Parallel Bio created a human 'immune system in a dish' to discover drugs and immunotherapies more likely to work in patients. Our platform has all of the same elements as a human immune system, meaning you can test drugs and vaccines as if you were testing them in actual patients from the start. The biggest reason why 95% of new drugs fail is that they were tested in mice - but with our human platform, pharma companies will know which drugs will successfully treat patients, speeding up the process and reducing the cost. To date our platform has successfully been used to test 12 drugs, and vaccines against 8 different diseases. The company is founded by Robert DiFazio, a former Stanford R&D director with a PhD in immunology, and Juliana Hilliard, a former System1 Biosciences R&D lead with an MSc in bioengineering, both of whom have led drug discovery programs for years.

US hospitals and clinics are losing $125B every year due to delayed and inaccurate medical coding. Arintra is solving this problem by automating medical coding using AI and clinical NLP. Arintra converts a patient chart instantly into insurance claims with 96% accurate medical codes and zero human intervention. Arintra has processed more than 1.63 million claims this year across its 20+ provider clients that includes health systems and large physician groups. Through automation of these charts, Arintra has reduced undercoding by 11% and coding-related claim denials by 43%. Arintra is headquartered in Austin, Texas. Arintra is bi-directionally integrated with leading EHRs including Epic, Cerner, etc. to process patient charts directly from the EHR to create a direct-to-billing claim. This direct-to-billing claim includes precise E/M levels, CPT, ICD-10, HCC, HCPCS codes with appropriate modifiers and units. Both founders have PhDs in AI, significant ML and NLP experience, 60+ patents and publications, and a combined 20+ years of experience working at B2B companies and startups in Silicon Valley.

Carrot is a simple and affordable way for companies of any size to build or enhance their fertility benefit. Carrot can help with egg freezing, infertility treatments including in vitro fertilization (IVF), LGBT+ conception, and more. Fertility care is daunting and scary; our focus is on improving the employee experience during high impact moments related to fertility-- helping save time, money and stress.

Attunement an automation workflow platform for psychiatric assessments.

Getting paid in healthcare is hard. Healthcare providers contract with numerous payors, all of which have their own systems and processes for authorizing payment. Worse, payor systems don't communicate with provider EMRs, so providers are forced to do a lot of manual work between them to get paid. This results in providers spending $300 Billion a year to get paid, and ultimately collect less money than what they are owed. CoreCare aggregates administrative patient data from all systems providers work with (EHR, Gov, Payer), standardizes it in our Enterprise Data Warehouse and creates a single net view of administrative patient data for the provider. Then we add workflow automations (according to client specifications) to eliminate the manual work providers are forced to do to get paid.

ParcelBio is developing a programmable technology to safely and specifically deliver mRNA to diverse cell types in the body. Our proprietary (nanoparticle-free) technology, which we call ‘STAmP’, stabilizes the mRNA and utilizes an interchangeable, lock-and-key-like targeting mechanism which enables fully customizable mRNA medicines.

Andy is AI software that completes documentation for nurses doing home visits. Our software saves $8B a year; Tiantian was previously a PM at Google’s healthcare business and Max was a staff engineer on the health team at Apple. Andy benefits nurses and the agencies that employ them. Agencies that use Andy see up to 45% more detailed charts, 2x greater nurse productivity, and timely submission (no more billing delays!) With Andy, clinicians get their evenings back. Home health is the fastest growing segment of healthcare, doubling to $251B by 2031. Combined with recent nursing shortages and burnout, we’re seeing not just urgency, but excitement and joy, around adopting AI for home health.

Culture Biosciences grows cells for biotech companies. Our customers genetically modify organisms to produce new therapeutics, materials, fuels and foods. We help them quickly run experiments and develop manufacturing processes so they can get their products to market faster. We've built proprietary software and automation systems to make operating our bioreactors more efficient than existing systems. We also provide customers with new software tools that help them analyze and contextualize their data. We are currently serving a number of biotech customers and scaling out our infrastructure.

We connect healthcare workers (physicians, advanced practitioners, nurses and allied health workers) to hospitals/clinics/telehealth companies for short/full time job opportunities.

Cell and gene therapy promises to one day cure any disease; Modulari-T’s Platform produces the tools to fulfill that promise. Modulari-T has designed a new family of synthetic genes that can reprogram cells to better sense their environment and modify their behavior accordingly. This can be used to engineer immune cells to efficiently recognize and kill cancer cells or to create stem cells able to regenerate any tissue. Modulari-T looks to expand its technology to reach every area of cell therapy and become the platform of reference for cell engineering.

Menten AI designs protein drugs and enzymes using quantum computing and machine learning. Their technology leapfrogs current computational methods making it possible to design previously intractable proteins. The team created the first protein design algorithm for current and near-term quantum computers and created the world’s first protein designed on a quantum computer. They are now working on 3 new proteins, including a peptide to prevent the spread of viruses like Covid-19. They have 2 paid pilot projects with multinational chemical companies and 4 LOI’s with pharma and biotech companies.

ACX is the only company that has successfully reproduced the compounds that bacteria use to kill microbes for therapeutic development. Our patentable technology, which comprises synthetic compounds that mimic natural substances, has applications in humans, animals, and crops. We are beginning with the elimination of crop pathogens—harmful to pests but beneficial for humans!

R.care is not just another diet program or calorie-counting app. It's a comprehensive, evidence-based solution designed to address the root causes of binge eating and provide lasting recovery. Say goodbye to waiting lists and hefty price tags, and take control of your relationship with food.

Synaptiq's mission is to become the AI infrastructure for the $110B medical education industry, leading to better physicians, a more efficient healthcare system, and improved patient care.

Readily helps healthcare organizations find and close compliance gaps in hours not weeks. We do that by connecting over 100,000 pages of policies, and regulations, enabling staff to conduct research, analysis, and audits faster. This saves them hours of work, boosts readiness, and helps them avoid costly violations.

PostEra is building a modern 21st century biopharma. We're using our advances in machine learning to accelerate Medicinal Chemistry and bring more cures to patients. PostEra advances small molecule programs through partnerships with biopharma while also advancing its own internal pipeline. We've raised $26M from top investors and closed $1Bn in AI partnerships, signing multi-year agreements with Amgen, Pfizer and the NIH. PostEra also launched and led the world's largest open-science drug discovery effort; COVID Moonshot.

There are 10 million dialysis and bypass surgeries per year, but half of them fail. VenoStent saves lives with a wrap that goes around blood vessels during surgery so they don't fail.

At InVision, we use AI to help streamline the interpretation of ultrasounds and identify diseases that may have been missed by human readers. Our models have been tightly integrated into the clinical workflow to allow easy usage by clinicians. Our work has previously been peer-reviewed and published in several top medical venues, including Nature (2020), Nature Medicine (2021), Lancet Digital Health (2021), JAMA Cardiology (2022). Results from our blinded and randomized clinical trial on evaluating cardiac function have also been recently presented as a Late Breaking Clinical Trial at the European Society of Cardiology.

Akute Health makes an electronic medical record (EMR) system & digital infrastructure tools used by digital health companies to track patients. Our EMR is a web app used daily by clinical teams at digital health companies similar to Ro, Hims, and One Medical. In 2015, I was diagnosed with cancer and spent 9 months in the hospital. While in the hospital, I built an app to track my own records. I needed something that was simple to use and allowed me to easily track & trend different types of data. I later turned that app into a full medical record system. We now have hundreds of customers and over 50k active patient records. We are building the de facto EMR for digital health companies.

Gilgamesh is a pioneering, clinical stage mental health science-focused biotechnology company. We have a disciplined focus on developing innovative new chemical entities (NCEs) leveraging a unique combination of medicinal chemistry, intellectual property strategy, neuroscience & neurobiology, and drug development expertise. We are an experienced team, with proven success in biotech exits and inventions.

Pillar is a white-label care enablement solution transforming how organizations scale engagement with their resources. Our mobile-friendly experience centralizes access to their suite of healthcare services, digital benefits and educational programming, while surfacing the right resource at the right time using automated navigation workflows. Pillar’s platform simultaneously captures engagement, satisfaction and utilization data, enabling our partners to maximize the value of their resources and improve operational efficiency. For organizations seeking human-led engagement, Pillar offers staffing and placement solutions from our leading workforce of over 1,000 vetted health coaching providers.

Rev Genomics is a plant biotechnology company that provides breeders, growers, and retailers with novel cultivars to differentiate themselves in high value markets.

Rebellyous Foods is a food manufacturing technology and production company defined solely to catapult meat alternative production toward price parity with animal-based meat. Rebellyous implements novel food manufacturing equipment and processes in large-scale production to produce low-cost plant-based meat at high volumes. These goals are achieved through uniquely designed food products, the use of high-throughput manufacturing automation and ‘smart’ production centers, and the development and utilization of new innovative low-energy manufacturing tools. Working closely with industry partners, Rebellyous makes plant-based meat sustainable, affordable, and widely available.

SynsoryBio is creating next generation, protein therapeutics that sense where they are in the body and only activate at diseased tissue. This technology platform has the potential to expand the therapeutic window of highly potent drugs and apply to many diseases such as cancer and autoimmune disorders.

Rosebud Biosciences accelerates drug development by screening drugs against organoids (micro-organs) that have the same gene mutations as the patients. We partner with therapeutics companies to screen their drugs, and we perform our own drug discovery for rare diseases that have no existing treatments. Our organoids are also fetal-like and enable discovery of novel drug targets for pediatric diseases. This technology was validated at Stanford, published in a prestigious journal, and has already led to the discovery of a drug target in a pediatric heart disease that could not have been found using traditional disease models.

We have developed an AI platform enabling to accelerate the discovery and the design of genomic therapies such as Cell Therapies, RNA Therapies and DNA Therapies.

We are a biotechnology company integrating AI, computation and biological automation to accelerate the design of small molecule and protein therapeutics. Our mission is to decrease the timeline and cost of drug development, while improving the success rate of bring innovative medicines to patients in need. We have two drug discovery engines - ELVIS™ and ROSALYND™ - that enable the design of both small molecule and protein therapeutics, an unmatched capability in the AI drug discovery space. Our therapeutic area-agnostic, end-to-end technology powers the full length of early drug discovery - from novel hit discovery to hit to lead, and lead optimization. We are currently applying our technology to drug discovery programs in several areas including, but not limited to, neuroscience, infectious disease, immunology and oncology.

Healthcare is delivered by teams – nurses, doctors, and staff, specific to each hospital, clinic, and department. They want to do their best, but cannot keep up with constantly changing information. Burnout >50%. Unprecedented turnover. Growing medical errors (the #3 cause of death in the US). $100B+ in waste. Elemeno Health is a UCSF and Y Combinator-backed B2B SaaS for healthcare facilities– “a playbook in your pocket,” customized to support frontline teams with bite-sized training and communication at their fingertips, accessible 24/7 on any device. Our efficacy is demonstrated in our published results, passionate clients, and consistent renewals. 20x ROI. 75% decrease in medical errors.

SaveIN connects people with quality healthcare practices near them and enables them to split their entire medical and wellness bills into monthly instalments. Over 80% of healthcare expense in India is borne out of pocket since less than 10% of Indians have private health insurance. On top of this medical inflation is 15% per annum, thereby making paying for private care expensive and frictional. 5000+ healthcare practices in India now use SaveIN to be discovered by millions of high intent customers near them and offer instant, monthly payment plans for all healthcare services, thereby making it a win-win proposition for all.

YourChoice Therapeutics is revolutionizing the global contraceptive market. Our vision is to develop non-hormonal contraceptives to provide both women and men with birth control options that lack the associated risks of hormone-based options but are equally effective. Traditionally, it has been the women’s financial and health burden to have a contraceptive in place. Our first goal is therefore to bring a novel non-hormonal, on-demand and low cost female contraceptive to the market that will substantially improve their quality of life and well-being. Our second goal is to develop the first ever non-surgical and highly effective non-hormonal contraceptive for men. Currently, male contraception is limited to two main options – vasectomy or condoms. Having such options available to both women and men will globally allow for much better family planning, reduce the number of unwanted pregnancies including abortions and therefore reduce costs and ensure contraceptive health and well-being.

We’re on a mission to leverage AI and voice technology to solve inefficiencies and revenue leakage in our healthcare system. With the rise of EHRs, the manual documentation burden on doctors has never been higher, leading to burnout and fatigue and high attrition rates. Assigning the correct diagnosis and billing codes is crucial for proper reimbursement and patient care, but medical coding is becoming more and more complex each year with growing numbers of codes (over 145,000 now), and doctors are unsupported by current technology to keep up with its ever increasing requirements. $125 billion is left on the table each year by healthcare organizations due to improper documentation and coding. Knowtex creates visit notes with up-to-date and accurate reimbursement codes from doctor-patient conversations, allowing the doctor to focus on patient care and preventing revenue leakage for hospital systems through standardized, transparent, and accurate documentation.

Planbase has everything modern clinics need to manage their team in one place: capacity planning, employee scheduling, availability management, credentialing and payroll.

Argon AI is a platform where biopharma and life sciences professionals can execute complex and data driven workflows using natural language. We help professionals get thorough answers to questions about clinical trials, existing treatments, healthcare landscape, and the competitive market in minutes rather than months. Prior to starting Argon, Samy was responsible for Flatiron Health’s (Roche) first data analytics project which eventually led to the start of the Flatiron Services business unit. There, he saw first-hand the heavily manual process that biopharma companies struggle through to get the insights they need to drive forward their drug development programs. He also helped close over $6M+ in ARR and is an expert in enterprise pharma sales. Cyrus previously led engineering teams and built 0 to 1 across pre-seed and unicorn startups, managed mission-critical trade generation systems at Bridgewater, and held AI advisory roles at various startups. Cyrus has a duel degree in EE and CS from USC. Breakthroughs in AI present an opportunity to reinvent biopharma and life science workflows to reduce the time and cost of bringing treatments to patients where delays in bringing a drug to market can cost a pharma company $3M / day.

Subscription model pharmacy for patients with chronic diseases in Latin America. We delivery medicine every month and help with the insurance reimbursement. We're currently operating in Mexico.

AOA Dx is developing the next frontier in early-stage cancer detection for women through our pioneering work in glycolipids and proprietary biomarker technology.

We're a SaaS company with emphasis on Service, and we have a mission: to improve the happiness of scientists and the quality of their research. HappiLabs provides a service called the Virtual Lab Manager. We offer PhD level, former scientists to help with safety and regulatory, product research, lab shopping, negotiating, purchasing, inventory, and bookkeeping. Our software tools, such as the ETA Dashboard and the HappiApp, make it easy to request purchases, manage inventory, and check-in packages upon delivery. HappiLabs also has one of the most extensive databases of product prices. These tools, and experienced humans, make us the smartest lab managers in the world. Another way to think of us is an outsourced purchasing department and/or a personal assistant for your scientists. Based in Chicago, and some presence in San Francisco. If you're a newly funded PI, a startup, small biotech, or work with purchasing as a big pharma/biotech, you can use our help.

Orchid is an AI-powered Electronic Health Record (EHR) for independent mental health professionals that saves them time, money, and frustration by integrating core administrative workflows, streamlining clinical processes, and automating manual flows.

In 1935 the Social Security Act set the retirement age to 65. At the time, the average life expectancy of an American was 62. A lot has changed in the last 83 years. The average American now lives until 79. The people turning 65 today were 45 during the first dot-com boom. The fastest growing segment on Tik-Tok is seniors. It took 20 years, but the internet has finally arrived for seniors. But most of the products that seniors use are distinctly “pre-web” - they’re cumbersome and exploitative. When seniors buy healthcare, they have to talk to an insurance agent over the phone. These agents are exactly what you’d expect - they don’t know much about health insurance and they push Mom and Dad into the plan they get the highest commission on. When seniors look to for liquidity, reverse mortgage brokers take advantage of their financial illiteracy. When seniors look for companionship, they find themselves isolated in the suburbs they originally moved to to raise a family. We are acutely aware of these problems because we see our own parents experience them. Fair Square is fixing them. Fair Square’s goal is to be a company seniors trust. To advise them on health insurance and financial planning. To find them a book club or an Art History lecture at a local community college. To have the customer experience of a five-star hotel and the care and respect of a relative. We started by building a customer obsessed health insurance brokerage for seniors. We’ve worked with 10,000 people across the United States. Our NPS score is 98, compared to an industry average of 13. Join us and build the rest.

We are building the technical infrastructure to train and pay the 53M family caregivers in the US.

Pyrls is a website and mobile app that enables healthcare providers to more effectively prescribe, dispense, and educate patients on their prescriptions. Currently trusted by 50,000+ clinicians and trainees and hundreds of organizations, Pyrls is building the future of how clinicians learn and manage their clinical practice information.

Forty million men in the US and over 500 million worldwide suffer from urinary obstruction related to benign prostatic hyperplasia (BPH). The majority of men will experience symptoms of this disease at some point in life. BPH, also known as prostate enlargement, leads to urinary straining, frequency, urgency, and sleep disruption. Despite the high prevalence and significant quality of life burden of BPH, established treatments are limited to drugs, which have limited effectiveness, and surgery, which carries a high risk of sexual side effects. The Zenflow Spring is a small implant delivered in the urologist's office in a simple procedure that provides quick and long-lasting symptom relief.

We develop surgical navigation and robotics tools to make minimally invasive surgeries easier, faster and more accessible.

Reframe is the leading app to help people cut back on drinking. Reframe uses neuroscience & psychology to help people shift the way they think about drinking & help build great habits. We don't believe in stigma or restrictions. In the past 12 months, Reframe has had over 2M+ users and has helped more people cut back on alcohol use than any other org worldwide.

Today's funders are so conservative they only fund the most obvious ideas. At Experiment, we fund the ideas that they won't fund; the ideas that matter. Since founding, over 47,000 citizens have pledged $9 million dollars supporting 900 scientific projects on the platform. 46% of all projects on Experiment are successfully funded. When the projects are finished, the scientists share the scientific results with their backers as lab notes and peer-reviewed publications. Scientists from Stanford, Harvard, and Yale have chosen to use Experiment instead of writing grants. Bill Gates recognized Experiment by saying "this solution helps close the gap for potentially-promising but unfunded projects."

Auricle is a medical device company building a breakthrough neurostimulation implant to restore hearing in millions of patients who no longer benefit from hearing aids, get less than 60% on a word recognition test, but aren't prepared to make the jump to a cochlear implant. Our approach preserves remaining natural hearing through a reversible and less invasive surgery, addressing the key concerns that hold most patients back from getting a cochlear implant (currently the only treatment option for these patients). The company spun out of Stanford Biodesign having completed two acute human clinical studies demonstrating the approach will work. The team is now focused on developing their full implant system for their first clinical trial. Auricle addresses a currently unserved profile of hearing loss that affects a growing population of 3.5 million patients in the US and represents an immediately accessible $1.2B market opportunity with existing reimbursement.

At iMicrobes, we believe there are opportunities for biology to solve our biggest problems. Our mission is to work with the world’s largest companies to use new raw materials and recycle waste for chemical production, polymers, agriculture, and space exploration.

LunaJoy is a precision mental health platform that is specialized in women's mental health through all phases of life including adolescence, pregnancy, postpartum, infertility, miscarriage, loss, perimenopause, and aging. We deliver care by creating a specialized workforce to provide targeted psychotherapy, medication management + genetic testing, coaching, and holistic wellness. LunaJoy utilizes technology and data science to provide intelligent touchpoints that decrease costs and accelerate outcomes. We are increasing our in-network footprint to provide truly accessible care for all. Women are twice as likely to experience mental health difficulties. Rates are even higher for women of color and LGBTQ+ folks. Women are 3x more likely to experience sexual, physical, emotional trauma which is a predictor for mental illness. This is just the tip of the iceberg! Physiologically, women experience hormonal fluctuations which make them more vulnerable to mental health issues during times of transition such as puberty, pregnancy, postpartum, and menopause. We also face unique stressors as the emotional bedrock of our homes, supporting young families, elderly adults, and a huge part of the workforce. The downstream effects of this gap in care are far-reaching into our ecosystems. Currently, mental health care is expensive, inconvenient, and generalist where a specialized approach is needed. When we attend to women’s mental health, we all shine brighter!

Over 80% of maternal mortalities were preventable with earlier intervention. Currently, doctors miss >50% of moms who have life-threatening complications and wait until labor to start doing manual risk assessments, at which point it's too late. Elythea's proprietary ML models catch life-threatening obstetric complications (like postpartum hemorrhage, preeclampsia/eclampsia, emergency c-section, preterm labor, and more) as soon as the first visit. We automatically analyze relevant demographic and clinical risk factors, flag high-risk patients, and provide evidence-based interventions, giving doctors months in advance to intervene and prevent complications from ever happening. Our global clinical studies have shown that we can catch 3x more complications than clinical judgment 10x sooner.

CB Therapeutics is a synthetic biology company focused on bringing cannabinoid and tryptamine therapeutics to the clinic and commercial markets to treat depression, PTSD, opioid addiction, alcoholism, pain, and other mental health problems.

Meru Health is an online provider for greater mental health with remote clinicians (licensed therapists & psychiatrists), a smartphone-based treatment program, a biofeedback wearable and an anonymous peer-support group. Meru Health is committed to evidence-based care and has published groundbreaking clinical outcomes in several peer-reviewed medical journals with Harvard & UC Davis. Meru Health has offices in San Mateo CA, Denver CO and Helsinki, Finland.

SelectIQ addresses the primary bottleneck in drug development: recruiting patients into clinical trials. We analyze electronic health records to help doctors find clinical trials for their patients, and to help trial sites find patients for their studies. 72% of doctors want to inform their patients of clinical trials, but only 5% do. We're on a mission to close that gap, ultimately bringing safer, more effective drugs to the patients who need them.

Pipe|bio is the bioinformatics cloud for antibody / peptide screening & drug development. We enable scientists to analyze and manage massive amounts of DNA sequencing data themselves without the need for bioinformaticians or programmers. The software is highly visual and enables you to overlay and filter information from different sources across your organization; be it assay data, sequence data or other process metadata. Insights from past results can be used to guide new experiments and they get better as you upload more and more data. Team leads get oversight and these capabilities combined empower organizations to find better drugs, faster. We believe that science moves faster when scientists can curate and analyse their own data.

Pelago, formerly Quit Genius, is the world’s leading virtual clinic for substance use management. We are transforming substance use support—from prevention to treatment—delivering education, management skills, and opportunities for positive change to members struggling with substance use, most commonly tobacco, alcohol, or opioids. Our solution gives employers the means to offer on-demand, personalized support to workers seeking to live healthier lives. Pelago’s cognitive behavioral therapy (CBT) and medication-assisted treatment (MAT) programs deliver convenient, accessible, and effective support that seamlessly integrates with health plans, pharmacy benefit managers, and wellness platforms. To date, Pelago has helped more than 750,000 members manage their substance use and improve their lives.

We’re building the AI copilot for radiologists, powered by a foundational model for medical imaging. RadMate AI will read radiology images and generate full reports for radiologists to review and submit. Mohamed and Adam are technical co-founders who met while studying Computer Science at Cornell University. Before starting RadMate AI to solve the problems his dad faced as a radiologist, Adam worked at Palantir on the initial launch of Palantir’s Al Platform. Mohamed has experience at AWS, where his goal was to help enterprises innovate on the cloud, and PathAl, where he worked on their image viewer platform to improve the workflow of pathologists.

Daybreak offers comprehensive and clinically-validated online mental health services designed for youth, like teletherapy, psychiatry and digital education. We partner with schools and pediatric groups to make access to services easy, and strive to deliver zero cost to the end consumer through insurance and government funding.

Triomics is helping cancer care providers by reducing the burden associated with manually reviewing patient charts. Utilizing our OncoLLM™—a family of oncology-focused language models—we are able to accelerate clinical trial enrollment, power quality improvement projects, and address many other key strategic priorities.

Shiok Meats is a cell-based clean meat company, exclusively working on seafood. Shiok Meats is the first cell-based meat company in Singapore and SE Asia and we employ cellular agriculture to grow seafood meat in the laboratory using cells instead of animals. Shiok in Singapore English slang means fantastic and enjoyable. Our meats are animal-, health- and environment-friendly with the same taste, texture and nutrients, but no cruelty. Our mission is to bring delicious and healthy meat by harvesting from cells instead of animals.

Terapify offers high-quality on-demand mental healthcare for individuals and businesses. Currently, people in more than 45 countries take therapy with us on a recurring basis every month.

BrainKey is an AI-driven digital healthcare company with a mission to create a world free from dementia. The company specializes in developing advanced clinical technologies that empower longevity physicians to detect and prevent cognitive decline and other brain longevity challenges. By analyzing brain MRI and biomedical data, BrainKey provides highly accurate and personalized brain health insights, supporting physicians in delivering tailored care for brain longevity. BrainKey's AI-powered platform streamlines diagnostics and reporting, improving both clinical outcomes and financial efficiency across the continuum of brain health care. Short Clip about BrainKey from the BBC: https://www.youtube.com/watch?v=ioSgvROTP0E

Sample builds financial infrastructure for healthcare so that doctors can focus on their patients. We help healthcare providers, like clinical labs, get paid by health insurance by automating steps across their billing process.

Kernal Bio creates mRNA 2.0 therapies that instruct specific cells on how to make their own medicine. Kernal Bio encrypts mRNA’s “message” in a language that only cancer cells understand. These tumor-specific mRNA therapeutics allow precise targeting of cancer cells, without harming normal cells or tissues. They have recently been validated in preclinical tumor models, showing high efficacy and safety as well as durable adaptive immunity. With roots at MIT, Harvard and Biopharma, Kernal’s management team has deep expertise in mRNA therapeutics space. CEO Yusuf Erkul, M.D., M.B.A. is a successful drug hunter whose research at Merck enabled an FDA-approved drug for ovarian cancer. President, Burak Yilmaz, M.S., previously founded Sentegen, a thriving synthetic biology company which commercializes synthetic DNA, RNA, and diagnostic kits for genetic and infectious diseases. VP of BD, Matt Strout, M.D. Ph.D., M.B.A, is a business development executive who led more than $4.5B worth of BD deals at Alexion and AstraZeneca. VP of R&D Manfred is a leader in immuno-oncology, who was most recently Scientific Senior Director at Bristol-Myers Squibb (BMS).

Patients enter their insurance and visit reason, and we use machine learning to predict and guarantee their out-of-pocket costs for every health provider. For health providers, we ensure their patients always pay the bill.

Syntra is the all-in-one solution for private practice doctors. Our operating system includes a personalized EHR that automates administrative tasks for doctors, such as patient intake, scribing, billing, and inventory management. Practices are switching off of solutions they have used for over a decade, calling Syntra "the only solution that doesn’t need to be managed.”

Today, biologists spend too much time pipetting by hand. We think biologists should have robots to do pipetting for them. People doing science should be free of tedious benchwork and repetitive stress injuries. They should be able to spend their time designing experiments and analyzing data. That's why we started Opentrons. We make robots for biologists. Our mission is to provide the scientific community with a common platform to easily share protocols and reproduce each other's results. Our robots automate experiments that would otherwise be done by hand, allowing our community to spend more time pursuing answers to some of the 21st century’s most important questions.

Fitia is an automated meal planner and nutrition tracker for weight loss or muscle gain. Our users get personalized recipes based on their data and their local country ingredients, supported with an exclusive database of 1M foods & recipes.

Diffuse is building generative AI for protein design. Our mission is to build AI systems that engineer new and useful proteins with unprecedented control and accuracy. Our team has been behind breakthroughs in AI protein design for the past 7 years, including the first experimental validation of AI-generated proteins and diffusion models for protein structure and sequence.

We are developing utility-scale molecular sensing using gamified citizen science and a unique, toy-like R&D device.

Archform is teeth aligner software startup that lets orthodontists create, design and 3D print aligners within their own offices. The idea is to provide orthodontists with a way to better compete against some direct-to-consumer teeth aligner startups and cut down on the cost of Invisalign.

MetricWire’s mobile platform allows decision makers, researchers, and stakeholders to harness unparalleled insights solutions, analytical tools, and deeper audience connections. Our innovation has lead to real-time digital interventions, enriched research, and evidence-based decisions. Capture more powerful data and make better decisions

Reverie Labs is engineering next-generation, brain-penetrant cancer therapies.

Wyndly (https://www.wyndly.com) fixes allergies by training patients' bodies to ignore their allergy triggers. Frustrated allergy suffers come to us when they no longer want to deal with pills and sprays. We diagnose the patient’s unique allergy profile and create a personalized treatment plan to give the patient lifelong allergy relief. Specifically, Wyndly is increasing access to sublingual immunotherapy (SLIT) for allergy care. For our patients, we're combining the convenience of telehealth and direct-to-consumer care with an exceptional patient experience that never loses the context of care. Wyndly represents an opportunity to change allergy care forever. With 60 million Americans suffering from allergies today, and with this number doubling over the coming years, there's simply an incredible need for the convenient care Wyndly provides. You can read more about us in [Techcrunch](https://techcrunch.com/2021/02/12/wyndly-aims-to-bring-allergy-drops-to-the-masses/). The Wyndly Model At Wyndly, we believe that better connections lead to better care, and we’re committed to making both happen at every step of the patient journey. Our allergy practice allows our patients to work with expert providers to develop personalized treatment plans for long-term allergy relief using clinically proven therapies. From a patient’s initial consultation to their final treatment delivery, we want the Wyndly experience to be a breath of fresh air for allergy sufferers – truly effective allergy relief, simply and efficiently delivered. Once we've conquered allergies, we're transforming the care model for every chronic condition. While transactional care for purchasing pills has flourished in telehealth, no one has gone after chronic care. Patients with chronic conditions are shuffled between providers, insurance, and more -- and they never feel heard. These patients deserve better, and we're going to give it to them. Wyndly is starting with allergies, but we'll expand into asthma, sleep apnea, and other conditions in the near future. Our values **Compassion**: We approach all our patients and partners with an open mind and a genuine desire to be of service. **Focus**: We do a few things very well, and are always clear about our boundaries and direction of travel. **Courage**: We embrace ambiguity and discomfort because we know that’s how we grow. **Progress**: We make something better every single day. *It boils down to empathy and forward momentum in everything we do.* The team Wyndly is proudly backed by Y Combinator and a leading group of angel investors and VCs. The founders are Dr. Manan Shah (Chief Medical Officer), an ear-nose-and-throat surgeon who’s a leading practitioner of telehealth in his specialty, and his cousin Aakash Shah (CEO), who led growth engineering at SparkGift (acquired by Stockpile in 2016) and Parse.ly (acquired by Automattic in 2021).

25 million Americans with chronic insomnia are getting inadequate and superficial care advice (e.g. cutting coffee, meditation etc.), when in reality, their sleep problems are often driven by deeper psychological challenges like unresolved anxiety. Stellar Sleep uses psychology to help these people break the insomnia cycle.

We are making a new fertility treatment that infertile couples can order with a click of a button to help them conceive at home. Our technology increases the likelihood of pregnancy by guiding significantly higher number of sperms towards the ovum using a proprietary combination of surface features and microenvironment optimization. The fertility treatments available today, such as in-vitro fertilization (IVF) and intra-uterine insemination (IUI), are psychologically and financially draining and come with considerable treatment-associated risks. Furthermore, over 25 million women of reproductive age in the US have limited nearby access to fertility treatment.

What we do? We develop digital therapeutics to address unmet medical needs in hematology and oncology. How it works? First we build networks of doctors and patients designed to track, predict and prevent disease. Second, we validate the safety and efficacy of our interventions in pivotal clinical studies to obtain regulatory clearance (SaMD). Finally, we aim to commercialize our products as prescription digital therapeutics (DTx). Where are we now? Today, we are the standard in digital hematology: * Our hemophilia network covers 33% of all patients and providers in the US. * We bested 20+ competitors, including several Fortune 500 companies. * Our clients include: Sanofi, Bayer, Novo Nordisk, Biogen, and Roche.

We make devices that help cancer patients prevent the side effects of cancer treatment, including hair loss, neuropathy and infertility. Our first product, Lily, is a wearable cap that enables chemotherapy patients to prevent hair loss in a comfortable, portable way, while our second product, Lilac, is the world's first device to prevent the peripheral nerve damage caused by cancer treatment.

38 million people suffer from heart rhythm disorders and are recommended to start medications that can save their lives, but require rigorous ECG monitoring to start and remain on these pills. SafeBeat Rx moves beyond diagnostics to guide these therapeutics, powered by our ML ECG software that integrates with existing FDA-cleared wearables to allow seamless physician approval of drug dosing, all from a mobile phone. We are a team of physicians, engineers, data scientists, and machine learning experts dedicated to using engineering to improve heart health.

Equipt Health makes it easy for any healthcare company to offer prescription medical devices to patients. We handle the whole process: the packaging, the logistics, the clinical (via our provider network) and technical support, and the return of data from connected devices. We're starting with the diagnosis and treatment of sleep apnea at heliosleep.com.

Kairo Health builds AI agents that help deliver patient care at a fraction of the cost. The US has a shortage of nurses, care coordinators, and administrators, all of whom spend a significant portion of their days navigating disparate software systems like their EHR and waiting on hold for hours over the phone. Organizations have little incentive to grow these teams, which leads to burnout and inefficiency. Kairo scales this support staff by recording their actions and translating them into instructions for our agents to execute on their own. Organizations can deploy these agents for any care delivery workflow, such as calling patients to check-in on their symptoms, rescheduling a clinician’s panel in case of an emergency, and filling late cancellation slots with other patients.

Digital health holds a lot of potential but is ignoring a growing problem: diagnostic testing. Without this data, providers and organizations will be limited in the services they can provide patients at home. Scout has developed a platform - Hub, test kits, and app - that delivers health testing at home with 10x lower development cost and 3x lower per-test price. Our patented tech also meets performance requirements for medical diagnoses and integrates with the current healthcare tech stack. Scout’s technology is poised to disrupt the outdated $33Bn diagnostic market by democratizing testing while dramatically improving the patient experience. Scout has received $16M in non-dilutive funding from the NIH and other organizations to fully de-risk our platform, and our pipeline includes a diverse test menu for primary care (e.g. respiratory and sexual health), wellness (e.g. gut health), and chronic conditions (e.g. certain cancers). We have already received FDA authorization for our platform in clinical settings and are planning to launch our flagship Scout Hub in 2024.

Quadrant Eye is on a mission to improve eyecare access and fight preventable blindness. We're building the next generation eye exam... inside the average American home. Our team wants to enable patients' best and most visually rich lives. To this end, we're looking for curious and nimble minds to help us develop the world's first fully online eye exam and ultimately deliver high-quality eyecare at scale. Some QE highlights: 🐝 We're a team of surgeons, scientists, venture partners, and hackers who mean business. 💸 Our backers include Y Combinator, Khosla Ventures, and the creator of Google Image Search. 🍥 We're a mission-driven company tackling an eye health market worth $USD137B. 🌟 Our core focus is currently the development of patentable deep tech, and our overall vision is to change eyecare for good.

We help hospitals 🏥 hire nurses 🧑🏻‍⚕️ from all around the world 🌏 and with technology make the complexity of immigration and licensing simple.

Intellect is a modern-day mental health company on a mission to make mental healthcare & wellbeing support accessible for everyone in Asia. Today, Intellect is the largest and fastest growing mental health tech company in Asia, serving over 2.5 million members and leading organisations globally through our mental health platform. Intellect was also selected as one of Google’s Best Apps of 2020. Intellect is backed by leading investors including Insignia Ventures Partners, Y Combinator, and an extensive list of family offices, big tech executives & renowned angel investors.